Oryzon Genomics Eulerpool Novinky

Oryzon Genomics Eulerpool News

Oryzon Genomics Novinky o akciách

Oryzon Genomics sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy Oryzon Genomics zhromažďujeme práve tu.

• 3. septembra ·

  Yahoo
  ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat with Additional “Decision to Grant” Communications
• 29. augusta ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in September
• 31. júla ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024
• 8. júla ·

  Yahoo
  ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
• 28. júna ·

  Yahoo
  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
• 26. júna ·

  Yahoo
  ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
• 14. júna ·

  Yahoo
  ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
• 3. júna ·

  Yahoo
  ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
• 30. mája ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in June
• 29. mája ·

  Yahoo
  ORYZON Selected as Associated Partner in the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)